C&EN White Paper
Fast and accurate protein-ligand binding prediction for drug discovery
Brought to you by VeraChem
Overview

Identifying ligands that bind a target protein with high affinity is central to most drug discovery projects. Existing computational approaches to predict protein-ligand binding, however, face a stark mismatch in throughput and accuracy. Free energy perturbation (FEP) methods, for example, offer improved accuracy but can only process a small number of ligands.

VM2 is a binding free energy prediction software that offers both accuracy and speed. Built on a mining‑minima, physics‑based framework, VM2 estimates protein–ligand binding free energies with accuracy approaching that of FEP but with much shorter calculation times.

Key Objectives:
  • How VM2’s mining‑minima approach for estimating binding free energies works
  • VM2’s performance relative to FEP methods, comparing both accuracy and speed
  • Steps involved in setting up and running a VM2 calculation

Brought to you by:
VeraChem Logo
Please complete the form to download the white paper.
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

Copyright © 2026 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy